Abiraterone acetate plus ADT most cost effective option for metastatic prostate cancer in the USA Clinical study 02 October 2021 Pages: 1 - 1
Adding aprepitant to the standard antiemetic regimen may be cost effective for CINV in China Clinical study 02 October 2021 Pages: 2 - 2
Adjuvant homeopathic treatment, SilAtro-5-90, cost effective for recurrent tonsillitis in Germany Clinical study 02 October 2021 Pages: 3 - 3
AI software cost saving in detecting large vessel occlusions in stroke Clinical study 02 October 2021 Pages: 4 - 4
An automated development safety update report tool appears to be cost saving in the US setting Clinical study 02 October 2021 Pages: 5 - 5
Catch-up HepA vaccination reduces HepA morbidity and mortality, saves cost in the US Clinical study 02 October 2021 Pages: 6 - 6
ClonoSEQ minimal residual disease testing in multiple myeloma patients saves costs in Germany Clinical study 02 October 2021 Pages: 7 - 7
Community health worker-led hypertension management programme cost effective in Argentina Unknown 02 October 2021 Pages: 8 - 8
Durvalumab cost effective in unresectable stage III NSCLC Clinical study 02 October 2021 Pages: 9 - 9
Evolocumab cost effective for atherosclerotic CVD, familial hypercholesterolaemia in KSA Clinical study 02 October 2021 Pages: 10 - 10
Extended-release tapentadol cost effective vs branded and generic oxycodone/naloxone in Italy Clinical study 02 October 2021 Pages: 11 - 11
Global health spending set to grow, but remain unequally distributed between countries Unknown 02 October 2021 Pages: 12 - 12
Headache-related work-loss costs substantial in Portugal Clinical study 02 October 2021 Pages: 13 - 13
Implanting trabecular meshwork bypass stents during cataract surgery cost effective in the USA Clinical study 02 October 2021 Pages: 14 - 14
Informal care hours and societal costs in patients with dementia Clinical study 02 October 2021 Pages: 15 - 15
Kidney exchange programs with altruistic donors increase health value Clinical study 02 October 2021 Pages: 16 - 16
Lung transplantation may be a cost-effective option "under some circumstances" Clinical study 02 October 2021 Pages: 18 - 18
Many symptom-control drugs for cancer have high and widely-variable costs in the USA Clinical study 02 October 2021 Pages: 19 - 19
Medication reviews have a positive cost-benefit ratio in a hospital setting in the Netherlands Clinical study 02 October 2021 Pages: 20 - 20
Nivolumab more effective, but too costly, for head and neck cancer in Brazil Clinical study 02 October 2021 Pages: 21 - 21
No significant change in total healthcare costs with aripiprazole lauroxil Clinical study 02 October 2021 Pages: 22 - 22
Patients with chronic hepatitis C have high out-of-pocket costs in Canada Clinical study 02 October 2021 Pages: 23 - 23
Pembrolizumab + axitinib likely most cost-effective option for advanced RCC in the USA Clinical study 02 October 2021 Pages: 24 - 24
Pneumococcal vaccination reduces antibacterial failure and costs Clinical study 02 October 2021 Pages: 25 - 25
Pregnancy-related and long-term complications of PCOS costly in the USA Clinical study 02 October 2021 Pages: 26 - 26
Rapid infusion protocol of iron polymaltose saves cost in management of iron deficiency anaemia Clinical study 02 October 2021 Pages: 27 - 27
Risk-based cervical screening practice more cost effective in the USA than results-based approach Clinical study 02 October 2021 Pages: 28 - 28
Sacubitril/valsartan appears to be cost effective for acute decompensated HF in Thailand Clinical study 02 October 2021 Pages: 30 - 30
Secondary hyperparathyroidism increases healthcare costs Clinical study 02 October 2021 Pages: 31 - 31
Subcutaneous IG replacement therapy may be cost saving for PID in Spain Clinical study 02 October 2021 Pages: 32 - 32
Vaborem may be cost effective for carbapenem-resistant Enterobacteriaceae infections in the UK Clinical study 02 October 2021 Pages: 33 - 33
Would RSV vaccination be cost effective in the Netherlands and the UK? Clinical study 02 October 2021 Pages: 34 - 34
ICER has released draft evidence report on tezepelumab for severe asthma News item 02 October 2021 Pages: 35 - 35
NZ Pharmac funds upadacitinib for people with RA affected by tocilizumab stock shortage Media release 02 October 2021 Pages: 36 - 36
NZ's Pharmac to fund tocilizumab for moderate-to-severe cases of COVID-19 News item 02 October 2021 Pages: 37 - 37
SMC accepts selpercatinib, pembrolizumab and filgotinib for routine use by NHS Scotland News item 02 October 2021 Pages: 38 - 38